The Motley Fool Previous Page

Why Epizyme Inc. Shares Were Hammered

Sean Williams
November 14, 2013

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Epizyme (NASDAQ: EPZM), a clinical-stage biopharmaceutical company focused on de